Every week, Rinchem shares important articles and topics about chemical and gas logistics, industries we operate in, and the general global supply chain. In this week's review we discuss a 3PL market research report, drug tariffs, and using data to solve supply chain vulnerabilities.
Keep reading to see this week's hot topics.
This week's stats
90% of all U.S. prescriptions are filled with generic drugs Axios
2026 Inbound Logistics Perspectives 3PL Market Research Report
The 2026 Inbound Logistics 3PL Market Research Report finds that third-party logistics providers are experiencing strong business growth despite ongoing market uncertainty, with higher sales, profits, and customer acquisition reinforcing the increasing strategic value of outsourced logistics. While operational costs, capacity constraints, tariffs, and compliance remain significant challenges, many 3PLs are responding by investing in AI, supply chain visibility, and technology to improve efficiency and resilience. The report also highlights that shippers increasingly view AI implementation as a top priority while continuing to value customer service and reliability over cost when selecting logistics partners, underscoring the growing importance of technology-enabled, service-focused 3PL relationships.
Trump's generic drug tariffs will test his pharma strategy
The Axios article examines how the Trump administration's proposed tariffs on imported generic drugs could challenge its broader pharmaceutical strategy of reshoring manufacturing while keeping prescription drug prices affordable. The plan would give manufacturers until August 2028 to establish U.S. production before tariffs take effect, with the goal of reducing reliance on overseas suppliers and strengthening domestic supply chain resilience. However, industry experts warn that building U.S. manufacturing capacity will require billions of dollars in investment and years of construction, raising concerns that higher production costs could ultimately translate into increased drug prices or supply shortages despite the administration's assurances.
How deep data insights help chemical manufacturers solve supply chain vulnerabilities
The CAS article argues that chemical manufacturers can strengthen supply chain resilience by transforming fragmented operational, scientific, and regulatory data into actionable insights. As the industry faces persistent challenges from raw material shortages, logistics disruptions, and evolving regulations, companies are increasingly using centralized data platforms, predictive analytics, scenario modeling, and end-to-end supply chain visibility to identify risks before they escalate. The article highlights how leading manufacturers are leveraging data-driven decision-making to diversify sourcing, improve forecasting, enhance supplier collaboration, and maintain operational continuity in an increasingly volatile global environment.
Get more articles like this in your inbox
Sign up for our monthly newsletter
Find more articles
Request a Quote
